Publicaciones en colaboración con investigadores/as de Johns Hopkins University (1)

2017

  1. Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer

    Journal of Clinical Oncology, Vol. 35, Núm. 1, pp. 40-47